Summary of PK parameters
| . | rhFVIII . | rhFVIII + VWF-12 . | rhFVIII + VWF-13 . |
|---|---|---|---|
| Application route | IV | SC | SC |
| rhFVIII dose, IU/kg | 200 | 1000 | 1000 |
| cmax, IU/dL | 114.1 | 53.8 | 25.6 |
| tmax, h | 1 | 6 | 6 |
| t1/2, h | 2.8 | 7.2 | 2.8 |
| AUC, IU × h/dL | 838.7 | 773.6 | 303.1 |
| F, % | — | 18.5 | 7.2 |
| . | rhFVIII . | rhFVIII + VWF-12 . | rhFVIII + VWF-13 . |
|---|---|---|---|
| Application route | IV | SC | SC |
| rhFVIII dose, IU/kg | 200 | 1000 | 1000 |
| cmax, IU/dL | 114.1 | 53.8 | 25.6 |
| tmax, h | 1 | 6 | 6 |
| t1/2, h | 2.8 | 7.2 | 2.8 |
| AUC, IU × h/dL | 838.7 | 773.6 | 303.1 |
| F, % | — | 18.5 | 7.2 |
—, not applicable; AUC, area under the concentration curve; cmax, peak concentration; F, bioavailability; SC, subcutaneous; t1/2, apparent half-life; tmax, time to concentration peak.